Bringing the fundamentals into focus…
Back to Arcus Biosciences, Inc.
How Arcus Biosciences, Inc. stacks up
RCUS · against 1,216 other Healthcare companies
Growth
8/ 100
Near the bottom of its peers.
Ranked #1,114 of 1,217 · scores higher than 8% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including RCUS · Click a bar to see the companies
Why growth scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 96% of peers. Revenue growth: -55.3% vs peer median 6.1%
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- slower revenue growth over three years: weaker than 74% of peers. 3-year revenue growth: -1.1% vs peer median 5.8%
Metric by metric
Position: dot = RCUS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RCUS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -55.3% | 6.1% | 4% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -1.1% | 5.8% | 26% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around RCUS| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,114 | 285M USD | 8 | 38 | |
| 1,114 | 2.4B USD | 8 | 27 | |
| 1,114 | 31M USD | 8 | ||
| 1,114 | 1.3B USD | 8 | 20 | |
| 1,114 | 2.4B USD | 8 | 20 | |
| 1,114 | 3.4B USD | 8 | 55 | |
| 1,126 | 3.1B CNY (≈$437M) | 7 | 54 | |
| 1,126 | 9.3B CNY (≈$1.3B) | 7 | 32 | |
| 1,126 | 2.7B CNY (≈$383M) | 7 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score